Skip to main content
SpringerLink
Log in

Regenerative medicine − what price for a cure?

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anastasaki E, et al. An Update on Clinical and Economic Evidence Requirements for Advanced-Therapy Medicinal Products in Europe. 17th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes : (plus poster) abstr. PHP240, 8 Nov 2014. Available from: URL: http://www.ispor.org/RESEARCH_STUDY_DIGEST/list.asp?qs=38398.

  2. Faulkner E, et al. What Value Do We Place on a Cure? Value Demonstration Challenges Associated with Innovator and Regenerative Therapies in the EU, North America and Asia. 17th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes : (plus oral presentation) abstr. IP6, 8 Nov 2014. Available from: URL: http://www.ispor.org.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Regenerative medicine − what price for a cure?. PharmacoEcon Outcomes News 717, 32–33 (2014). https://doi.org/10.1007/s40274-014-1757-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1757-3

Search

Navigation